Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: Five Lives MED to Improve Cognitive Function in Mild Cognitive Impairment [NA]

View source ↗

Summary

The document reports that a SharpTx-sponsored trial evaluates Five Lives MED to improve cognitive function in individuals with Mild Cognitive Impairment and is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Five Lives MED

Snippet

Sponsor: SharpTx | Conditions: Mild Cognitive Impairment | NA | Status: RECRUITING